Pittenger & Anderson Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-162
| Closed | -$115K | – | 447 |
|
|
2024
Q4 | $115K | Hold |
162
| – | – | ﹤0.01% | 252 |
|
|
2024
Q3 | $170K | Hold |
162
| – | – | 0.01% | 239 |
|
|
2024
Q2 | $170K | Sell |
162
-13
| -7% | -$13.7K | 0.01% | 229 |
|
|
2024
Q1 | $168K | Hold |
175
| – | – | 0.01% | 233 |
|
|
2023
Q4 | $154K | Hold |
175
| – | – | 0.01% | 234 |
|
|
2023
Q3 | $144K | Hold |
175
| – | – | 0.01% | 213 |
|
|
2023
Q2 | $126K | Hold |
175
| – | – | 0.01% | 229 |
|
|
2023
Q1 | $144K | Hold |
175
| – | – | 0.01% | 225 |
|
|
2022
Q4 | $126K | Sell |
175
-25
| -13% | -$18K | 0.01% | 229 |
|
|
2022
Q3 | $138K | Hold |
200
| – | – | 0.01% | 217 |
|
|
2022
Q2 | $118K | Hold |
200
| – | – | 0.01% | 229 |
|
|
2022
Q1 | $140K | Hold |
200
| – | – | 0.01% | 232 |
|
|
2021
Q4 | $126K | Buy |
+200
| New | +$126K | 0.01% | 239 |
|